We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

IBM Watson Turns Oncogenes Into Drug Targets

News   Aug 09, 2017 | Original story from Medical College of Georgia at Augusta University

 
IBM Watson Turns Oncogenes Into Drug Targets

Dr. Ravindra Kolhe, breast and molecular pathologist at the Medical College of Georgia at Augusta University

 
 
 

RELATED ARTICLES

"Superhuman" AI Plays Five Pros Off the Poker Table

News

An artificial intelligence program developed by Carnegie Mellon University in collaboration with Facebook AI has defeated leading professionals in six-player No-Limit Texas Hold'em poker, the world's most popular form of poker.

READ MORE

Toxin in Bacteria Hijacks and Modifies Human Proteins

News

A team of scientists discovered that the toxin SidJ in Legionella bacteria enforces a unique modification on human proteins and helps legionella grow inside human cells.

READ MORE

Gene Loss 2 Million Years Ago May Explain Why Humans Are Prone to Heart Attacks

News

Researchers say the loss of a single gene two to three million years ago in our ancestors may have resulted in a heightened risk of cardiovascular disease in all humans as a species, while also setting up a further risk for red meat-eating humans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE